We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Galapagos Signs Research Agreement with UCL

News   May 21, 2008

 
Galapagos Signs Research Agreement with UCL
 
 
 

RELATED ARTICLES

HPV-Positive Throat Cancer Patients Should Keep Taking Chemotherapy

News

Patients with human papillomavirus (HPV)-positive throat cancer should carry on receiving chemotherapy rather than switching to a targeted cancer drug during curative radiotherapy, new clinical trial results have shown.

READ MORE

Arming Drug Hunters: Chemists design new reaction for drug discovery

News

The pair of Colorado State University organic chemists have forged a powerful new tool for drug hunters - a simple, elegantly designed chemical reaction that could fling open an underexplored wing of biologically relevant chemistry.

READ MORE

Drug Candidate Could Recover Vocal Abilities Lost to ADNP Syndrome

News

A new Tel Aviv University study finds that the drug candidate CP201, also known as NAP, may improve vocal communication abilities that are underdeveloped in Activity-dependent neuroprotective protein (ADNP) patients.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE